Cerebral uptake of a  3 H-labelled spirolactone compound in the dog.
D000818:Animals; D001812:Blood-Brain Barrier / Q000187:drug effects*; D001921:Brain / Q000378:metabolism*; D001923:Brain Chemistry; D002540:Cerebral Cortex / Q000032:analysis; D004285:Dogs; D006914:Hydroxysteroids / Q000032:analysis / Q000134:cerebrospinal fluid / Q000378:metabolism; D007664:Ketosteroids / Q000032:analysis / Q000134:cerebrospinal fluid / Q000378:metabolism; D000451:Mineralocorticoid Receptor Antagonists; D010477:Perfusion; D011245:Pregnadienes / Q000032:analysis / Q000134:cerebrospinal fluid / Q000378:metabolism*; D011422:Propionates / Q000032:analysis / Q000134:cerebrospinal fluid / Q000378:metabolism; D013148:Spironolactone / Q000032:analysis / Q000134:cerebrospinal fluid / Q000378:metabolism*; D013997:Time Factors; D014316:Tritium
D006914:Hydroxysteroids; D007664:Ketosteroids; D000451:Mineralocorticoid Receptor Antagonists; D011245:Pregnadienes; D011422:Propionates; D014316:Tritium; D013148:Spironolactone